Clinical Trials Browser

Phase 2 × Carcinoma, Adenoid Cystic × Axitinib × Clear all

NCT03990571 2024-10-18

Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Phase 2 Completed

40 enrolled 13 charts

Carcinoma, Adenoid Cystic, Disease Progression

NCT01558661 2017-11-28

Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

Phase 2 Completed

33 enrolled 10 charts

Carcinoma, Adenoid Cystic, Neoplasm Metastasis, Recurrence